Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

Mallinckrodt strikes $20M RNAi pact with Silence Therapeutics

Il y a 4 jours
Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at the complement cascade, a group of proteins that help antibodies and other immune cells fight off pathogens,...
www.fiercebiotech.com
Bandeau FranceBiotechnologies
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57

UK VC Medicxi Closes Third Fund with €400M to Boost European Biotech

Il y a 5 jours
The UK-based venture capital investment firm Medicxi has closed its third fund, totaling €400M, to nurture early- and late-stage healthcare biotech companies in Europe. The firm will begin investing...
labiotech.eu
Une actualité de L'Usine Nouvelle a été ajouté(e)
Hier à 16:04

1 200 traitements et vaccins menacés de pénurie en 2019 en France

Il y a 2 jours
C’est le nombre de traitements et de vaccins risquant des tensions d’approvisionnements et des pénuries en 2019 en France. Un chiffre en augmentation de... - L'Usine Santé
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43

Illumina alums launch Cradle Genomics with $17.1M for first-trimester fetal DNA testing

Il y a 4 jours
Prenatal blood test developer Cradle Genomics has secured $17.1 million to help build out its laboratory operations, as well as kick off clinical testing of its methods for fetal genetic testing and...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05

CVS kicks off first trial of its home dialysis device

Il y a 4 jours
CVS Health has launched a long-awaited trial to test out its at-home dialysis device designed to provide more frequent and thorough treatments compared to those offered in the clinic....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12

This Biotech Breaks Down ‘Undruggable’ Proteins to Treat Cancer

Il y a 4 jours
In the Polish city of Wroc?aw, Captor Therapeutics is developing cancer treatments that destroy disease-causing proteins. Mission: To develop cancer treatments able to degrade proteins that are...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52

Novartis licenses out early antiviral work to Gilead

Il y a 4 jours
Just two days after announcing its R&D chief was stepping down, Gilead Sciences has announced it will be buying up a few of Novartis’ unwanted early-stage infection assets....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

Il y a 4 jours
The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with the UK pharma company Mallinckrodt to develop RNA interference (RNAi) therapies for autoimmune...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Hier à 07:36

NASH-linked gene discovery could inspire new drugs to treat liver damage

Il y a 4 jours
A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in patients with nonalcoholic steatohepatitis (NASH). They believe the finding will inspire new...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Bischofberger-helmed Kronos bags $105M to tackle tough targets

Il y a 5 jours
Kronos Bio has raised $105 million. The series A sets the Norbert Bischofberger-helmed biotech up to advance efforts to hit historically undruggable targets. ...
www.fiercebiotech.com
Charger plus d'actualités